HER2-specific CAR-T cells

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HER2-specific CAR-T cells, covering 2025-09-05 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma [Phase 1]